latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Pharmabiz
Sat, 05/05/12 - 4:38 pm
Last 30 twitter posts
-
Find out more about RNAi in our Hub t.co/SNxpf18bCA
Latest Health Message Board Posts
... of chemicals etc. Selective stimulation of the nerve is a therapeutic method to treat depression and epilepsy. However ... Heart/Cardiovascular Disease. "Learn to get in touch with the silence within yourself, and know that everything in this life has purpose ...
Posted by:
4est
at
2013-04-30 05:00:00
on
medhelp.org
... could be expected. Yes, he did cycle through many emotions---anger, panic, crying, silence,anger, f-bombs,panic, sobbing....all normal, but, he did leave calmly with the therapeutic transport team and I have been hearing that he is calm and resting in the ...
Posted by:
StephenCastlecrag
at
2013-04-26 05:00:00
on
medhelp.org
... they should feel or what they should do. Just listen... that is what he needs most right now, quiet support. It's called "therapeutic silence". Share fond memories of the deceased. Do not make his or her name "taboo". The bereaved need very much to talk ...
Posted by:
studyforhope
at
2013-03-28 05:00:00
on
medhelp.org
... capable of extremely efficient gene silencing that can be used for a variety disease targets." About Arrowhead Research Corporation Arrowhead Research Corporation is a clinical stage targeted therapeutics company with development programs in oncology ...
Posted by:
ronny12
at
2013-03-25 05:00:00
on
medhelp.org
... patent protects a new masking chemistry that broadens the reach of DPC-enabled RNAi therapeutics. It enables efficient subcutaneous delivery of siRNA and opens up new therapeutic area targets including oncology," said Dr. Chris Anzalone, President and CEO ...
Posted by:
StephenCastlecrag
at
2013-02-28 06:00:00
on
medhelp.org
The formation of drug effect blocking antibodies is always a concern with macromolecular therapeutics. With regard to Myrcludex, the doctoral thesis of Alexa Schieck has shown that in a rat study the existing antibodies, despite a high titer against ...
Posted by:
studyforhope
at
2013-02-28 06:00:00
on
medhelp.org
... chronic for over thirty years and has persisted despite prior therapy with multiple anti-viral drugs and therapeutic vaccine exposures. “Treating this animal represented a very difficult challenge,” said Dr. Chris Anzalone, President and CEO of Arrowhead ...
Posted by:
StephenCastlecrag
at
2013-02-28 06:00:00
on
medhelp.org
... with interferon plus myrcludex plus therapeutic vaccine after initial hbsag conversion. 95% true long term svr. Replicor plus ifn plus myr 85 Replicor plus ifn 80 Replicor alone 25 Myr alone 20 Limited time silencing RNA..arrowhead..10 Irbesartan plus ...
Posted by:
Steve n Dallas
at
2013-02-04 11:03:00
on
healingwell.com
... similar to that observed with IFN?, and lead to persistent cccDNA silencing. Lymphtoxin beta receptor (LTbR) agonisation represents basis for novel alternative therapeutic approach to curing chronic HBV infection. The final study demonstrated that ...
Posted by:
stkitt
at
2013-01-01 15:45:00
on
healingwell.com
... similar to that observed with IFN?, and lead to persistent cccDNA silencing. Lymphtoxin beta receptor (LTbR) agonisation represents basis for novel alternative therapeutic approach to curing chronic HBV infection. The final study demonstrated that ...
Posted by:
illhangin
at
2012-12-17 08:09:00
on
mdjunction.com